Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine
Clinical trial NCT05718037 · UNKNOWN
Trial details
- NCT number
- NCT05718037
- Sponsor
- Wuhan BravoVax Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-01-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.